SCHEMBL2656759

SCHEMBL2656759

CCC(Oc1cccc(C(=O)OC(C)(C)C)c1)C(=O)Nc1nccs1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.54
▸ NPC1 O15118 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ RECQL P46063 1/20 0.48
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.45
▸ LMNA P02545 3/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ FFAR2 O15552 1/20 0.45
▸ HTT P42858 2/20 0.44
▸ TSHR P16473 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ TP53 P04637 1/20 0.43
▸ HSPA5 P11021 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2656269 0.87 HPGD (0.59) HPGDNPC1RAB9ASMN1; SMN2RECQL
SCHEMBL2656757 0.82 NPC1 (0.52) HPGDNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL14223786 0.82 LMNA (0.61) HPGDNPC1RAB9ASMN1; SMN2RECQL
SCHEMBL2657624 0.80 NPC1 (0.53) HPGDNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL2656142 0.77 MEN1 (0.57) HPGDNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL14194995 0.77 PPARA (0.48) HPGDNPC1RAB9ASMN1; SMN2RECQL
SCHEMBL1565655 0.73 HSPA5 (0.52) HPGDNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL27652020 0.71 RAB9A (0.74) HPGDNPC1RAB9ASMN1; SMN2RECQL
SCHEMBL1566200 0.69 NPC1 (0.58) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL1564841 0.69 CYP1A2 (0.55) HPGDNPC1RAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125735-A2 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION Advinus Therapeutics Private Limited (IN) 2009-12-02 — — EP disclosed
WO-2008104994-A2 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2008-09-04 — — WO disclosed
Send feedback